Published on: December 7, 2013
by Nigel Atkins for Mirror:
A test has been developed which can predict the onset of Alzheimer’s two years earlier than previously.
And a team at the University of Montreal, Canada, said it was 90% accurate.
Currently the disease is often diagnosed late in its development and sometimes up to ten years after the first pathological changes have affected the brain.
A challenge for doctors has been to provide earlier diagnosis so that patients can receive treatment as early as possible.
Prof Sylvie Belleville said: “When used individually, neuroimaging and neuropsychology are effective but only up to a certain point.
“It is when combining and analysing the results from both methods that we could achieve such an exceptional level of accuracy.
“For the moment, we can’t diagnose this disease very early due to the lack of reliable protocols. Thus, there is a risk of erronously identifying the disease when trying to diagnose it too early.
“The innovation here is showing that two different approaches can be combined to aid in diagnosis.
“The clinical benefits of these extra two years are enormous.
“We can now evaluate the effectiveness of pharmacological and non-pharmacological therapies on the outcome of a clinical diagnosis of Alzheimer’s disease in people identified with these tools.
“We could assess whether these treatments are more effective when administered earlier.”
The study was published in the Journal of Alzheimer’s Disease.
Older people who report greater levels of social engagement have more robust gray matter in regions of the brain relevant in dementia, according to new research led by scientists at the University of Pittsburgh Graduate School of...
In a new study, University of Nebraska–Lincoln sociologist Marc A. Garcia explored how educational attainment can benefit cognitive health in later life, and whether there are differences in its benefits among minorities. Garcia and his co-authors...
A genetic variation in some people may be associated with cognitive decline that can’t be explained by deposits of two key proteins associated with Alzheimer’s disease, amyloid β and tau, according to a study...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.